Therapeuticsmd — Corporate Update (December 2018)

4 slides from Therapeuticsmd's corporate update, Dec 18, 2018

Slide 1: Investor Update
Investor Update December 18, 2018
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation by TherapeuticsMD, Inc. (referred to as “we” and “our”) may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, as well as statements, other than
Slide 3: IMVEXXY Launch Update: Strong Positive Trend Continues
IMVEXXY Launch Update Strong Positive Trend Continues November 17 through December 16, 2018 § Total units since launch ~52,200 paid scripts1 dispensed to ~22,500 patients § Nov. 17th – Dec. 16th total units of ~15,000 paid scripts1 § New highs continuing week-over-week2 § Most recent week of Decembe
Slide 4: Corporate Updates
Corporate Updates § Management’s sales of expiring 10-year vested options will be completed on December 20, 2018 § BIJUVA™ on track for 2Q 2019 launch, which will allow draw down of additional $75M from term loan facility with MidCap Financial § Company will highlight its key 2019 milestones at JP M